Viridien Shares Reach Unprecedented High Since 2020: +222% in One Year
Viridien is trading at 154.40 euros this Thursday, up 2.46% from the previous day. The stock has reached a peak not seen since 2020, extending a remarkable upward trend with nearly 20% gained in one week.
Breaking Past Barriers
This morning, Viridien's share price surpassed the 150.70 euros threshold, erasing a ceiling that dated back to the stock market collapse triggered by the Covid-19 pandemic in spring 2020. At 154.40 euros, the stock shows a one-year increase of 222.1% and a three-month rise of 29.1%, illustrating a spectacular recovery trajectory. This record contrasts with the general tone of European markets. The CAC 40 is down 0.06% in session, around 8,151 points, while the SBF 120 drops by 0.11%. The German DAX also loses 0.07%. At Wall Street, the previous session concluded on a positive note, with the S&P 500 closing up 1.05% and the Dow Jones up 0.69%. However, this American firmness does not suffice to lift the indices of the Old Continent this Thursday morning. Viridien thus distinctly stands out from the rest of the Parisian market with the vigor of its ascent.
Surpassing a Mid-Term Historic Peak
The crossing of this mid-term historical peak is accompanied by tight technical signals. Viridien's share price now moves above the upper limit of the Bollinger Bands, set at 146.75 euros, which is a classic signal of potential overbuying. Additionally, the 50-day moving average is at 126.71 euros and the 200-day average at 93.33 euros: the considerable gap between the current price and these benchmarks reflects the magnitude of the recent acceleration. The next key events to watch are the publication of the first quarter 2026 results, scheduled for May 5th. The general assembly is then planned for June 3rd. These milestones could be crucial catalysts to validate or not the valuation level reached this morning. The former resistance of 150.70 euros, now surpassed, could act as a support in the upcoming sessions if the stock were to retreat.